Coeptis Therapeutics Analyst Ratings
Coeptis Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Coeptis Therapeutics (COEP) rating was a initiated with a price target of $0.00 to $6.00. The current price Coeptis Therapeutics (COEP) is trading at is $1.75, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/13/2022 | 242.86% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 12/12/2022 | 242.86% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 12/13/2022 | 242.86% | EF Hutton | → $6 | 开始承保 | →购买 |
| 12/12/2022 | 242.86% | EF Hutton | → $6 | 开始承保 | →购买 |
What is the target price for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的目标价格是多少？
The latest price target for Coeptis Therapeutics (NASDAQ: COEP) was reported by EF Hutton on December 13, 2022. The analyst firm set a price target for $6.00 expecting COEP to rise to within 12 months (a possible 242.86% upside). 2 analyst firms have reported ratings in the last year.
Coeptis治疗公司(纳斯达克：COEP)的最新目标价是由EF Hutton于2022年12月13日报道的。这家分析公司将目标价定为6美元，预计CoEP将在12个月内上涨至242.86(可能上涨242.86)。去年有两家分析公司公布了评级。
What is the most recent analyst rating for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的最新分析师评级是什么？
The latest analyst rating for Coeptis Therapeutics (NASDAQ: COEP) was provided by EF Hutton, and Coeptis Therapeutics initiated their buy rating.
科普蒂斯治疗公司(纳斯达克代码：COEP)的最新分析师评级由EF Hutton提供，科普蒂斯治疗公司启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for Coeptis Therapeutics (COEP)?
Coeptis Treeutics(COEP)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coeptis Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coeptis Therapeutics was filed on December 13, 2022 so you should expect the next rating to be made available sometime around December 13, 2023.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Coeptis治疗公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Coeptis治疗公司的上一次评级是在2022年12月13日提交的，因此您应该预计下一次评级将在2023年12月13日左右提供。
Is the Analyst Rating Coeptis Therapeutics (COEP) correct?
分析师对Coeptis Treeutics(COEP)的评级正确吗？
While ratings are subjective and will change, the latest Coeptis Therapeutics (COEP) rating was a initiated with a price target of $0.00 to $6.00. The current price Coeptis Therapeutics (COEP) is trading at is $1.75, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Coeptis治疗(COEP)评级是以0.00美元至6.00美元的目标价启动的。Coeptis Treateutics(CoEP)目前的交易价格为1.75美元，在分析师的预测范围内。